EMB vs XBI
iShares JP Morgan USD Emerging Markets Bond ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.39% for EMB.
- • EMB pays a higher dividend yield (5.02%).
Side-by-side metrics
| Metric | EMB | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.39% | 0.35% |
Dividend yield Trailing 12-month yield. | 5.02% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $14.62B | $10.73B |
YTD return | 2.11% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.08 | 1.10 |
P/E ratio | — | — |
Last price | $95.96 | $164.28 |
Inception | — | — |
Issuer | iShares | State Street |
EMB top holdings
| XTSLA | BlackRock Cash Funds Treasury SL Agency | 0.96% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About EMB
EMB (iShares JP Morgan USD Emerging Markets Bond ETF) is USD-denominated emerging market government bonds. Managed by iShares, the fund carries $14.6B in assets under management, an expense ratio of 0.39%, a dividend yield of 5.02%. Its largest holding is BlackRock Cash Funds Treasury SL Agency (XTSLA), which represents 1.0% of the portfolio.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.